Form 4: Gilead Sciences Executive Sells Shares
Insider Transaction (Form 4)
Johanna Mercier, Chief Comm & Corp Aff Officer of Gilead Sciences, Inc., sold 28,000 shares of common stock on August 17, 2026.
Summary
- Option exercise/conversion: acquired 23,110 Common Stock at $66.64 ($1,540,050) on August 17, 2026; holds 144,344 after (Direct).
- Option exercise/conversion: acquired 1,890 Common Stock at $72.34 ($136,723) on August 17, 2026; holds 146,234 after (Direct).
- Open-market sale: disposed of 16,530 Common Stock at $137.37 ($2,270,643) on August 17, 2026; holds 129,704 after (Direct).
- Open-market sale: disposed of 11,470 Common Stock at $138.04 ($1,583,265) on August 17, 2026; holds 118,234 after (Direct).
- Option exercise/conversion: disposed of 23,110 Non-qualified Stock Option (Right to Buy) on August 17, 2026 (Direct).
- Option exercise/conversion: disposed of 1,890 Non-qualified Stock Option (Right to Buy) on August 17, 2026; holds 69,960 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $3,853,908 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Johanna Mercier — Officer (Chief Comm & Corp Aff Officer)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-17 | Option exercise/conversion | Common Stock | 23,110 | $67 | $1.5M | 144,344 |
| 2026-08-17 | Option exercise/conversion | Common Stock | 1,890 | $72 | $136.7K | 146,234 |
| 2026-08-17 | Open-market sale | Common Stock | 16,530 | $137 | $2.3M | 129,704 |
| 2026-08-17 | Open-market sale | Common Stock | 11,470 | $138 | $1.6M | 118,234 |
| 2026-08-17 | Option exercise/conversion | Non-qualified Stock Option (Right to Buy) | 23,110 | — | — | 0 |
| 2026-08-17 | Option exercise/conversion | Non-qualified Stock Option (Right to Buy) | 1,890 | — | — | 69,960 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-17 | Option exercise/conversion (23,110 shares) |
| 2026-08-17 | Option exercise/conversion (1,890 shares) |
| 2026-08-17 | Open-market sale (16,530 shares) |
| 2026-08-17 | Open-market sale (11,470 shares) |
| 2026-08-17 | Option exercise/conversion (23,110 shares) |
| 2026-08-17 | Option exercise/conversion (1,890 shares) |
Keywords
insider transaction, Form 4, GILD, GILEAD SCIENCES, INC., bearish, Johanna Mercier
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.